The safety of misoprostol

International Journal of Gynecology and Obstetrics

Volumn 94, Issue SUPPL. 2, 2006, Pages

  Hemmerling, Anke ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ABDOMINAL PAIN; ACUTE TOXICITY; ARTICLE; CAUSE OF DEATH; CHILL; DIARRHEA; DRUG FEVER; DRUG INDICATION; DRUG SAFETY; HUMAN; HYPERTHERMIA; INDUCED ABORTION; LABOR INDUCTION; MATERNAL MORTALITY; NAUSEA; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; STOMACH ULCER; TACHYCARDIA; WORLD HEALTH ORGANIZATION;

EID: 33845186856     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(06)60019-2     Document Type: Article

References (15)

1. Silverstein F., Graham D., Senior J., Davies H., Struthers B., Bittman R., et al. Misoprostol reduces serious gastro-intestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 123 4 (1995) 241-249
2. Herting R., and Clay G. Overview of clinical safety with misoprostol. Dig Dis Sci 30 11 Suppl (1985) 185S-193S
3. Wildeman R. Focus on misoprostol: review of worldwide safety data. Clin Invest Med 10 3 (1987) 243-245
4. Rostom A., Dube C., Wells G., Tugwell P., Welch V., Jolicoeur E., et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 4 (2002) CD002296
5. Graber D., and Meier K. Acute misoprostol toxicity. Ann Emerg Med 20 5 (1991) 549-551
6. Bond G., and Van Zee A. Overdosage of misoprostol in pregnancy. Am J Obstet Gynecol 171 2 (1994) 561-562
7. Bentov Y., Sheiner E., and Katz M. Misoprostol overdose during the first trimester of pregnancy. Eur J Obstet Gynecol Reprod Biol 115 1 (2004) 108-109
8. Austin J., Ford M., Rouse A., and Hanna E. Acute intravaginal misoprostol toxicity with fetal demise. J Emerg Med 15 1 (1997) 61-64
9. Chong Y., Chua S., and Arulkumaran S. Severe hyperthermia following oral misoprostol in the immediate postpartum period. Obstet Gynecol 90 4 Pt 2 (1997) 703-704
10. Chandhiok N., Dhillon B., Datey S., Mathur A., and Saxena N. Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India. Int J Gynaecol Obstet 92 2 (2006) 170-175
11. Gulmezoglu A., Villar J., Ngoc N., Piaggio G., Carroli G., Adetoro L., et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 358 9283 (2001) 689-695
12. Hofmeyr G., Ferreira S., Nikodem V., Mangesi L., Singata M., Jafta Z., et al. Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]. BMC Pregnancy Childbirth 4 1 (2004) 16
13. Lumbiganon P., Hofmeyr J., Gulmezoglu A., Pinol A., and Villar J. Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour. Br J Obstet Gynaecol 106 4 (1999) 304-308
14. Walraven G., Blum J., Dampha Y., Sowe M., Morison L., Winikoff B., et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. Bjog 112 9 (2005) 1277-1283
15. Hoj L., Cardoso P., Nielsen B., Hvidman L., Nielsen J., and Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 331 7519 (2005) 723